| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.35 | 4e-22 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.23 | 3e-14 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.26 | 3e-13 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.26 | 4e-13 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.24 | 8e-13 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-12 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-12 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.2 | 6e-12 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.23 | 2e-11 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.22 | 3e-11 |